- About Us
- Business Development
WALTON OAKS, SURREY – 9 Jan 2019 Zoetis UK Ltd
Following the update from Zoetis to the Veterinary Medicines Directorate (VMD) of an issue with supply of IsoFlo (Isoflurane), the volatile anaesthetic, restocking of the UK supply chain is scheduled to commence from February. We would like to provide the following update to our customers and the wider veterinary market on re-supply of the IsoFlo back in to the market;
Please be aware that Zoetis is working across its entire organisation and with stakeholders during this market wide challenge to expedite the return of IsoFlo to the market. In the meantime we thank you for your patience and we will continue our communications with you and wider partners as we work on supplying all available product to your wholesalers.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2017, the company generated annual revenue of $5.3 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.